Completed
Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy - CA209-580
Aggiornato:
10 maggio, 2024
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice